Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AP214 for Prevention of Kidney Injury in Cardiac Surgery
NCT01256372Phase 2Completed
- Sponsor
- Action Pharma A/S
- Start
- Oct 2010
- Primary completion
- Jun 2011
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of modimelanotide in acute kidney injury (AKI), sponsored by Action Pharma A/S. Started Oct 2010; status: completed.
02
Drugs
modimelanotide
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT01256372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01256372.